Centiva Capital’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-3,500
Closed -$1.14M 2607
2024
Q1
$1.14M Sell
3,500
-67
-2% -$16.4K 0.03% 601
2023
Q4
$680K Buy
+3,567
New +$674K 0.02% 813
2023
Q3
Sell
-25,433
Closed -$7.26M 2208
2023
Q2
$7.26M Buy
25,433
+24,317
+2,179% +$6.75M 0.16% 112
2023
Q1
$242K Buy
+1,116
New +$217K 0.01% 1148
2021
Q3
Sell
-3,959
Closed -$751K 1678
2021
Q2
$751K Buy
+3,959
New +$648K 0.02% 679

Other funds holding SWAV

Centiva Capital's SWAV Position: Q2 2024 in Review

Centiva Capital sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 3,500 shares — an estimated $1.14M sold.

Centiva Capital first reported a position in SWAV in Q2 2021 and held it in 5 quarters. The position peaked at $7.26M in Q2 2023. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • Centiva Capital reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Centiva Capital sold 3,500 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $1.14M.
  • Centiva Capital first reported a position in Shockwave Medical, Inc. Common Stock in Q2 2021 and held it in 5 quarters.
  • Centiva Capital's Shockwave Medical, Inc. Common Stock position peaked at $7.26M in Q2 2023.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on Centiva Capital's 13F filing for Q2 2024, filed 14 Aug 2024.